SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes-Reference-Cited by-同舟云学术

SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes

Published:2018-10-19 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ashwinbalaji Soundararajan,Senthilkumari Srinivasan,Gowripriya Chidambaranathan,Krishnadas Subbaiah,Gabelt B’ Ann T.,Kaufman Paul L.,Muthukkaruppan Veerappan

Funder

DST | Science and Engineering Research Board

U.S. Department of Health & Human Services | NIH | National Eye Institute

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-33932-8.pdf

Reference38 articles.

1. Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmolgy. 121, 2081–2090 (2014).

2. Quigley, H. A. & Broman, A. T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262–267 (2006).

3. Kapetanakis, V. V. et al. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br. J. Ophthalmol. 100, 86–93 (2016).

4. Stamer, W. D. & Acott, T. S. Current understanding of conventional outflow dysfunction in glaucoma. Curr. Opin. Ophthalmol. 23, 135–143 (2012).

5. Pattabiraman, P. P. & Rao, P. V. Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. Am. J. Physiol. Cell. Physiol. 298, C749–C763 (2010).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as selective ROCK2 inhibitors with anti-breast cancer migration and invasion activities;Bioorganic Chemistry;2024-10

2. NAD+ supplementation improves mitochondrial functions and normalizes glaucomatous trabecular meshwork features;Experimental Cell Research;2024-07

3. Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma;Current Drug Targets;2024-02

4. Small RNA Sequencing Reveals a Distinct MicroRNA Signature between Glucocorticoid Responder and Glucocorticoid Non-Responder Primary Human Trabecular Meshwork Cells after Dexamethasone Treatment;Genes;2023-10-27

5. Nanofibrous PCL-Based Human Trabecular Meshwork for Aqueous Humor Outflow Studies;ACS Biomaterials Science & Engineering;2023-09-19